Hyphens Pharma International (SGX:1J5) COGS-to-Revenue : 0.62 (As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Hyphens Pharma International COGS-to-Revenue?

Hyphens Pharma International's Cost of Goods Sold for the six months ended in Jun. 2023 was S$46.7 Mil. Its Revenue for the six months ended in Jun. 2023 was S$74.7 Mil.

Hyphens Pharma International's COGS to Revenue for the six months ended in Jun. 2023 was 0.62.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Hyphens Pharma International's Gross Margin % for the six months ended in Jun. 2023 was 37.50%.

Hyphens Pharma International COGS-to-Revenue Historical Data

The historical data trend for Hyphens Pharma International's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyphens Pharma International COGS-to-Revenue Chart

Hyphens Pharma International Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

COGS-to-Revenue

Get a 7-Day Free Trial

0.66

0.64

0.62

0.61

Hyphens Pharma International Semi-Annual Data
	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
COGS-to-Revenue	Get a 7-Day Free Trial										0.61	0.62	0.61	0.61	0.62

Hyphens Pharma International COGS-to-Revenue Calculation

Hyphens Pharma International's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	99.507	/	162.316
	=	0.61

Hyphens Pharma International's COGS to Revenue for the quarter that ended in Jun. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	46.692	/	74.711
	=	0.62

Hyphens Pharma International (SGX:1J5) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Hyphens Pharma International's Gross Margin % for the six months ended in Jun. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	46.692 / 74.711
	=	37.50 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Hyphens Pharma International COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hyphens Pharma International's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Hyphens Pharma International (SGX:1J5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Hyphens Pharma International Ltd (SGX:1J5) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

16 Tai Seng Street, Level 4, Singapore, SGP, 534138

Website

https://www.hyphensgroup.com

Hyphens Pharma International Ltd is a pharmaceutical company. Its segments include Specialty Pharma Principals segment; Proprietary Brands segment and Medical Hypermart and Digital segment. Specialty pharma principals segment engages in the business of selling and marketing specialty pharmaceutical products. Proprietary Brands segment develops, markets and sells own proprietary range of dermatological products and health supplement products through Hyphens and Ocean Health Singapore. Medical Hypermart and Digital is engaged in the wholesale of pharmaceuticals and medical supplies in Singapore through Pan-Malayan.

Hyphens Pharma International (SGX:1J5) Headlines

No Headlines